Left Atrium Auricle (LLA) closure

This presentation analyzes the feasibility of a program of percutaneous closure of the left atrium auricle (n = 54 p) in patients at high embolism risk and hospital based results – on 30 days. 

Solaci-euroPCR-AD-Damonte
A. Damonte
2012-05-15

More articles by this author

TAVI registry: Iberoamerica

The objective of this presentation (n = 1248 p, 43 centers in Europe and Latin America) is to evaluate immediate and long-term results of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....